Long-Term Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement: A Meta-Analysis of Time-to-Event Data
Highlight
- Transcatheter aortic valve implantation (TAVI) shows early superiority over surgical aortic valve replacement (SAVR) in preventing death or stroke, especially in high-risk patients.
- This benefit attenuates over the long term, with no statistically significant difference observed at 5-year follow-up across low, intermediate, and high-risk groups.
- Risk profile strongly influences event rates, with high-risk patients experiencing greater absolute benefits from TAVI over time.
Study Background
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.